Convenient and non-invasive, the tests will require only a simple blood draw.
We aim to develop our tests to enable easy access around the world, at affordable costs.
Our diagnostic tests will offer the highest accuracy and fastest results to make early detection and monitoring of disease progression possible -- a decade or more in advance of symptoms.
Durin Technologies is committed to improving early disease detection through our diagnostic tests. We focus on developing diagnostic tests for the most prevalent and devastating neurodegenerative disorders, including Alzheimer's and Parkinson's diseases.